Cigarette Smoke Exposure and the Acute Respiratory Distress Syndrome
- PMID: 26010690
- PMCID: PMC4737582
- DOI: 10.1097/CCM.0000000000001089
Cigarette Smoke Exposure and the Acute Respiratory Distress Syndrome
Abstract
Objective: The association between cigarette smoke exposure and the acute respiratory distress syndrome in patients with the most common acute respiratory distress syndrome risk factors of sepsis, pneumonia, and aspiration has not been well studied. The goal of this study was to test the association between biomarker-confirmed cigarette smoking and acute respiratory distress syndrome in a diverse cohort.
Design: Prospective cohort.
Setting: Tertiary care center.
Patients: Four hundred twenty-six critically ill patients with acute respiratory distress syndrome risk factors (excluding trauma and transfusion)
Interventions: : None.
Measurements and main results: We obtained smoking histories and measured urine 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanol (a biomarker of cigarette smoke exposure) on urine samples obtained at the time of study enrollment. The association between cigarette smoke exposure and acute respiratory distress syndrome differed based on acute respiratory distress syndrome risk factor (p < 0.02 for interaction). In patients with nonpulmonary sepsis as the primary acute respiratory distress syndrome risk factor (n = 212), 39% of those with acute respiratory distress syndrome were current smokers by history compared with 22% of those without acute respiratory distress syndrome (odds ratio, 2.28; 95% CI, 1.24-4.19; p = 0.008). Likewise, cigarette smoke exposure as measured by urine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol was significantly associated with acute respiratory distress syndrome in this group. The increased risk of acute respiratory distress syndrome in nonpulmonary sepsis was restricted to patients with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol levels consistent with active smoking and was robust to adjustment for other acute respiratory distress syndrome predictors. Cigarette smoke exposure as measured by history or 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol was not associated with acute respiratory distress syndrome in patients with other risk factors (e.g., pneumonia and aspiration).
Conclusions: Cigarette smoking measured both by history and biomarker is associated with an increased risk of acute respiratory distress syndrome in patients with nonpulmonary sepsis. This finding has important implications for tobacco product regulation and for understanding the pathogenesis of acute respiratory distress syndrome.
Conflict of interest statement
The authors have no conflicts of interest relevant to the work under consideration for publication. Drs. Calfee and Matthay have received research funding from Glaxo Smith Kline and served on advisory boards for Glaxo Smith Kline. Dr. Ware has served on advisory boards for Glaxo Smith Kline. Dr. Benowitz has consulted for Pfizer and Glaxo Smith Kline and has served as a paid expert witness in litigation against tobacco companies. All other authors have no interests to report.
The remaining authors have disclosed that they do not have any potential conflicts of interest.
Figures
Comment in
-
Primed for Injury: Cigarette Smokers and Acute Respiratory Distress Syndrome.Crit Care Med. 2015 Sep;43(9):2015-6. doi: 10.1097/CCM.0000000000001121. Crit Care Med. 2015. PMID: 26274703 Free PMC article. No abstract available.
References
-
- Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307:2526–2533. - PubMed
-
- NHLBI Clinical Trials Research Network for the Prevention and Treatment of Acute Lung Injury (PETAL Network) 2012 [cited 2014 March 20]. Available from: https://http://www.fbo.gov/index?s=opportunity&mode=form&tab=core&id=a0c....
-
- Lu Q, Sakhatskyy P, Grinnell K, Newton J, Ortiz M, Wang Y, Sanchez-Esteban J, Harrington EO, Rounds S. Cigarette smoke causes lung vascular barrier dysfunction via oxidative stress-mediated inhibition of RhoA and focal adhesion kinase. Am J Physiol Lung Cell Mol Physiol. 2011;301:L847–857. - PMC - PubMed
-
- MacNee W, Wiggs B, Belzberg AS, Hogg JC. The effect of cigarette smoking on neutrophil kinetics in human lungs. N Engl J Med. 1989;321:924–928. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HL103836/HL/NHLBI NIH HHS/United States
- R01 CA078603/CA/NCI NIH HHS/United States
- HL090833/HL/NHLBI NIH HHS/United States
- HL110969/HL/NHLBI NIH HHS/United States
- KL2 RR024130/RR/NCRR NIH HHS/United States
- 1P50CA180890/CA/NCI NIH HHS/United States
- CA78603/CA/NCI NIH HHS/United States
- R01 HL051856/HL/NHLBI NIH HHS/United States
- P30 DA012393/DA/NIDA NIH HHS/United States
- K23 DK088964/DK/NIDDK NIH HHS/United States
- K24 HL103836/HL/NHLBI NIH HHS/United States
- R37 HL051856/HL/NHLBI NIH HHS/United States
- P50 CA180890/CA/NCI NIH HHS/United States
- K23 HL116800/HL/NHLBI NIH HHS/United States
- HL112656/HL/NHLBI NIH HHS/United States
- KL2RR024130/RR/NCRR NIH HHS/United States
- 1P50CA18890/CA/NCI NIH HHS/United States
- R21 HL112656/HL/NHLBI NIH HHS/United States
- U01 HL081332/HL/NHLBI NIH HHS/United States
- HL081332/HL/NHLBI NIH HHS/United States
- K23 HL090833/HL/NHLBI NIH HHS/United States
- R01 HL110969/HL/NHLBI NIH HHS/United States
